نتائج البحث - Jon Rowland

  • يعرض 1 - 3 نتائج من 3
تنقيح النتائج
  1. 1
    Amifostine does not prevent platinum‐induced hearing loss associated with the treatment of children with hepatoblastoma

    Amifostine does not prevent platinum‐induced hearing loss associated with the treatment of children with hepatoblastoma حسب Howard M. Katzenstein, Kay W. Chang, Mark Krailo, Zhengjia Chen, Milton J. Finegold, Jon Rowland, Marleta Reynolds, Alberto S. Pappo, Wendy B. London, Marcio H. Malogolowkin

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Intensified Platinum Therapy Is an Ineffective Strategy for Improving Outcome in Pediatric Patients With Advanced Hepatoblastoma

    Intensified Platinum Therapy Is an Ineffective Strategy for Improving Outcome in Pediatric Patients With Advanced Hepatoblastoma حسب Marcio H. Malogolowkin, Howard M. Katzenstein, Mark Krailo, Zhengjia Chen, Laura C. Bowman, Marleta Reynolds, Milton J. Finegold, Brian Greffe, Jon Rowland, Kurt D. Newman, Richard B. Womer, Wendy B. London, Robert P. Castleberry

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Mutations in KAT6B, Encoding a Histone Acetyltransferase, Cause Genitopatellar Syndrome

    Mutations in KAT6B, Encoding a Histone Acetyltransferase, Cause Genitopatellar Syndrome حسب Philippe M. Campeau, Jaeseung Kim, James T. Lu, Jeremy Schwartzentruber, Omar Abdul‐Rahman, Silke Schlaubitz, David M. Murdock, Ming-Ming Jiang, Edward J. Lammer, Gregory M. Enns, William J. Rhead, Jon Rowland, Stephen P. Robertson, Valérie Cormier‐Daire, Matthew N. Bainbridge, Xiang‐Jiao Yang, Marie‐Claude Gingras, Richard A. Gibbs, David S. Rosenblatt, Jacek Majewski, Brendan Lee

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: